Sisram Medical (HKSE:01696) 3-Year Revenue Growth Rate : 28.20% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Sisram Medical 3-Year Revenue Growth Rate?

Sisram Medical's Revenue per Share for the six months ended in Dec. 2023 was HK$3.14.

During the past 12 months, Sisram Medical's average Revenue per Share Growth Rate was 1.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 28.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 20.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 10 years, the highest 3-Year average Revenue per Share Growth Rate of Sisram Medical was 28.20% per year. The lowest was -8.90% per year. And the median was 23.00% per year.

Competitive Comparison of Sisram Medical's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Sisram Medical's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sisram Medical's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Sisram Medical's 3-Year Revenue Growth Rate falls into.

Sisram Medical 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Sisram Medical (HKSE:01696) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Sisram Medical 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Sisram Medical's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sisram Medical (HKSE:01696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sisram Medical Ltd (HKSE:01696) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895

Website

https://www.sisram-medical.com

Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.

Sisram Medical (HKSE:01696) Headlines

No Headlines